Polybutylene terephthalate (PBT) is a semicrystalline thermoplastic polyester synthesized by transesterification of dimethyl terephthalate or esterification of purified terephthalic acid with 1,4-butanediol. Medical-grade PBT compounds are differentiated from standard injection-moulding grades by supplier control of residual catalyst metals, oligomer content, and additive packages that satisfy USP <88> Class VI and ISO 10993 test criteria. Typical unfilled medical PBT exhibits a melt volume-flow rate of 8–25 cm³/10 min at 250°C/2.16 kg under ISO 1133-1:2022, a melting point of 223–225°C by differential scanning calorimetry at 10 K/min, and a glass transition temperature of 45–60°C depending on crystalline fraction and moisture. Pre-drying is mandatory: hot-air desiccant drying at 120–130°C for 4–6 h to a residual moisture below 0.02% prevents hydrolytic chain scission in the barrel. In 70–80% relative humidity ambient storage, unsealed pellets can reach 0.05% moisture within 2 h, which is sufficient to reduce melt viscosity batch-to-batch if not corrected.

Medical-grade PBT is most often processed on all-electric injection-moulding machines with clamp forces from 500 kN to 1,500 kN. Screw L/D ratios of 20:1 to 24:1 and compression ratios of 2.0:1 to 2.5:1 are used; barrel profiles are set from 240°C at the feed throat to 260–270°C at the nozzle, with mould temperatures of 30–80°C to control crystallization and shrink. Unfilled PBT mould shrinkage ranges from 1.5% to 2.0% in flow direction and 1.0% to 1.5% transverse; 30% glass-fibre reinforced PBT reduces isotropic shrinkage to 0.3%–0.6% and increases tensile strength to 130–140 MPa under ISO 527-2. The fibre orientation gradient through a 1.0 mm wall may produce warpage if gate location is not optimized.

What Does USP Class VI Certification Actually Cover in PBT Compounds?

USP Class VI is assigned to a PBT compound when the material meets the biological reactivity limits of USP <88> after extraction under defined conditions. The test battery includes systemic injection, intracutaneous injection, and intramuscular implantation. Extraction vehicles are typically sodium chloride injection, 5% ethanol in saline, polyethylene glycol 400, and vegetable oil; extraction temperatures include 50°C for 72 h, 70°C for 24 h, and 121°C for 1 h. A PBT compound that receives USP Class VI certification has satisfied specified limits for acute systemic toxicity, intracutaneous irritation, and implantation response. The six classes of plastics in USP <88> are defined by extraction temperature and injection route; Class VI requires the highest temperature/time combination and is therefore frequently specified for PBT components used in parenteral and implant-adjacent devices. However, USP Class VI is not a replacement for an ISO 10993 biological evaluation plan; it is a material-level screen, and a finished-device technical file cannot rely solely on a supplier’s Class VI certificate if the component is a long-term tissue-contacting medical device.

Under ISO 10993-1:2018, a PBT component is categorized by contact duration: limited contact ≤ 24 h, prolonged contact 24 h to 30 days, and permanent contact > 30 days. The tissue contact type—surface, external communicating, or implant—drives endpoint selection. For a PBT luer connector in blood contact, the evaluation plan includes cytotoxicity (ISO 10993-5:2009), sensitization (ISO 10993-10:2010), irritation (ISO 10993-23:2021), hemocompatibility (ISO 10993-4:2017), and chemical characterization (ISO 10993-18:2020). Extract preparation follows ISO 10993-12:2021 with simulated solvents—polar and nonpolar—selected from saline, ethanol/water, and polyol or alternative fatty media. For exhaustive extraction, PBT granules or films are extracted at 121°C for 1 h or refluxed in selected solvents; the extract is then analysed by liquid chromatography–mass spectrometry and headspace gas chromatography–mass spectrometry. Quantitation thresholds for extractables are typically 0.1 µg/mL or lower for high-performance liquid chromatography methods. Toxicological risk assessment of identified extractables follows ISO 10993-17:2023.

When PBT Is Exposed to Gamma Versus Ethylene Oxide, What Shifts Occur?

Radiation sterilisation of PBT is validated under ISO 11137-1 and ISO 11137-2. Gamma doses commonly specified for medical PBT devices are 25 kGy, 40 kGy, or 50 kGy. At 25 kGy gamma, unfilled PBT typically retains more than 90% of tensile strength and shows little measurable change in flexural modulus; at 50 kGy, the unfilled material may exhibit a reduction in elongation at break of 20–50% relative to non-irradiated control when tested under ISO 527-2. Glass-fibre reinforced PBT retains tensile strength above 95% at 50 kGy but may show surface yellowing quantified by CIELAB delta E greater than 5 under ASTM D2244. Electron beam processing at 10 MeV and dose rates of 5–40 kGy/s exposes the component for seconds rather than hours; the thermal rise in thick sections can exceed 30°C and must be accounted for in dimensional tolerance validation. Radical scavenger packages such as hindered phenols and phosphites are typically added to radiation-stabilized PBT, and their depletion during irradiation is monitored by high-performance liquid chromatography in supplier technical bulletins.

Ethylene oxide sterilisation is governed by ISO 11135:2014. PBT components are preconditioned at 40–55°C and 50–70% relative humidity for 2–12 h, then exposed to 400–800 mg/L ethylene oxide for 2–6 h. Because PBT absorbs less than 0.08% moisture at 23°C/50% RH, the polymer is not significantly plasticized by the humidification step; however, residual ethylene oxide and ethylene chlorohydrin must be reduced by heated aeration at 40–50°C for 12–72 h to meet ISO 10993-7:2008 limits. The selection between radiation and ethylene oxide is therefore a balance between oxidative yellowing and elongation loss under radiation, and residual chemistry validation under ethylene oxide.

Reinforcement, Moisture Conditioning and Dimensional Tolerance Control

Glass-fibre reinforced PBT used in surgical instrument handles and orthodontic brackets is compounded on co-rotating twin-screw extruders with L/D 40:1 and specific energy inputs of 0.20–0.30 kWh/kg to disperse fibre without excessive fibre attrition. The retained fibre length distribution influences tensile strength and notched impact; a 30% short glass fibre PBT typically exhibits a notched Izod impact of 7–9 kJ/m² under ISO 180, while unfilled PBT is in the range 3–5 kJ/m². Dimensional stability in humid environments is better than polyamide because PBT moisture uptake is 0.08% at 23°C/50% RH, versus 2.5% or higher for nylon 6.6. However, PBT is not dimensionally stable under hot water or repeated steam sterilisation; cyclic exposure to 134°C saturated steam causes hydrolytic degradation that reduces molecular weight and embrittles thin sections. If a load-bearing PBT component is autoclaved for more than 100 cycles at 134°C, tensile elongation at break after ageing should be evaluated under ISO 527-2; published data for specific PBT grades under repeated autoclaving is limited. Glass transition near 55°C also limits continuous load-bearing use above 65–70°C because creep modulus declines at a rate that depends on filler content and crystallinity.

Orthodontic brackets and dental ligature clips use PBT because the material passes USP Class VI and offers enough toughness for repeated engagement and disengagement. In these applications, moulding cycle times below 25 s are achieved with hot runner systems and mould temperatures of 80°C; part weights of 0.2–1.5 g require micro-moulding units with screw diameters between 14 mm and 18 mm to avoid residence times exceeding 5 min at 260°C. For dry powder inhaler components and insulin pen housings, dimensional tolerances of ± 0.05 mm are common; this requires measured shrinkage compensation using cavity pressure sensors and holding pressure profiles that maintain gate freeze after 6–8 s. PBT in drug delivery devices is often combined with lubricious additives such as polytetrafluoroethylene or silicone oil; migration of these additives must be characterized under ISO 10993-18:2020 because they may appear as extractables and affect the toxicological risk assessment under ISO 10993-17:2023. For respiratory connectors, snap-fit retention force after 10,000 engagement cycles is evaluated on an Instron universal tester at 50 mm/min; glass-filled PBT may retain 80–90% of initial retention force depending on geometry.

Biocompatibility data packages for PBT are generated per device geometry, not polymer type alone

A PBT resin supplied with USP Class VI certification does not automatically confer ISO 10993 compliance for any finished device. The biological evaluation must account for surface area-to-volume ratio, extraction conditions from ISO 10993-12:2021, and the conversion process used to mould the component. Degraded oligomers, mould release residues, colourants, and heat stabilizer by-products can be introduced during injection moulding; these are not captured in a raw resin certificate. For regulatory submissions under ISO 10993-1:2018, the technical file should include a chemical characterization report with process-specific extractables data, a toxicological risk assessment, and justification for any omitted endpoints. Audits of PBT suppliers should verify that the USP Class VI certificate is supported by test article preparation records and that the Biological Master File is accessible for device-level design history records.

PBT is generally not specified for long-term implantable load-bearing applications because hydrolytic degradation in aqueous physiological environments is more rapid than polyether ether ketone or polysulfone. Published data for this specific configuration is limited, but accelerated ageing in phosphate-buffered saline at 60°C can be used to compare grades. Avoid combination with polycarbonate blends containing residual transesterification catalysts if the PBT component requires repeated autoclave cycles; the presence of moisture above 0.02% before melt processing will reduce molecular weight and lead to brittle failure at knit lines. For radiation-sterilized devices, post-irradiation annealing at 80–100°C for 2–4 h can reduce trapped radicals but may also increase crystallinity and dimensional change; this trade-off should be validated using differential scanning calorimetry and dimensional inspection after annealing.